The probiotic effectiveness in preventing experimental colitis is correlated with host gut microbiota

Frontiers in Microbiology

Volumn 9, Issue NOV, 2018, Pages

  Suwal, Sharmila ^a   Wu, Qiong ^a   Liu, Wenli ^a   Liu, Qingya ^a   Sun, Hongxiang ^a   Liang, Ming ^a   Gao, Jing ^a   Zhang, Bo ^a   Kou, Yanbo ^a   Liu, Zhuanzhuan ^a   Wei, Yanxia ^a   Wang, Yugang ^a   Zheng, Kuiyang ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biotherapy; Inflammatory bowel disease; Microbiota; Personalized medicine; Probiotics

Indexed keywords

PROBIOTIC AGENT; RNA 16S;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM LONGUM; COLON TISSUE; CONTROLLED STUDY; DNA ISOLATION; EXPERIMENTAL COLITIS; FECES ANALYSIS; INTESTINE FLORA; LIPID DIET; MALE; MICROBIAL COMMUNITY; NONHUMAN; PATHOGENESIS; PRINCIPAL COORDINATE ANALYSIS; SEQUENCE ANALYSIS;

EID: 85056309213     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.02675     Document Type: Article

References (40)

1. Abraham, B. P., and Quigley, E. M. M. (2017). Probiotics in inflammatory bowel disease. Gastroenterol. Clin. North Am. 46, 769-782. doi: 10.1016/j.gtc.2017.08.003
2. Chapman-Kiddell, C. A., Davies, P. S., Gillen, L., and Radford-Smith, G. L. (2010). Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 16, 137-151. doi: 10.1002/ibd.20968
3. Cheifetz, A. S., Gianotti, R., Luber, R., and Gibson, P. R. (2017). Complementary and alternative medicines used by patients with inflammatory bowel diseases. Gastroenterology 152, 415.e15-429.e15.
4. Cheng, L., Jin, H., Qiang, Y., Wu, S., Yan, C., Han, M., et al. (2016). High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis. Int. Immunopharmacol. 40, 1-10. doi: 10.1016/j.intimp.2016.08.018
5. Derwa, Y., Gracie, D. J., Hamlin, P. J., and Ford, A. C. (2017). Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther. 46, 389-400.
6. Dinan, T. G., Stanton, C., and Cryan, J. F. (2013). Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720-726. doi: 10.1016/j.biopsych.2013.05.001
7. El Hage, R., Hernandez-Sanabria, E., and Van de Wiele, T. (2017). Emerging trends in “Smart Probiotics”: functional consideration for the development of novel health and industrial applications. Front. Microbiol. 8:1889. doi: 10.3389/fmicb.2017.01889
8. Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., et al. (2015). Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6:6528. doi: 10.1038/ncomms7528
9. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785.
10. Groen, R. N., De Clercq, N. C., Nieuwdorp, M., Hoenders, H. J. R., and Groen, A. K. (2018). Gut microbiota, metabolism and psychopathology: a critical review and novel perspectives. Crit. Rev. Clin. Lab. Sci. 55, 283-293. doi: 10.1080/10408363.2018.1463507
11. Hand, T. W. (2016). The role of the microbiota in shaping infectious immunity. Trends Immunol. 37, 647-658. doi: 10.1016/j.it.2016.08.007
12. Hildebrandt, M. A., Hoffmann, C., Sherrill-Mix, S. A., Keilbaugh, S. A., Hamady, M., Chen, Y. Y., et al. (2009). High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716.e1-2-1724.e1-2. doi: 10.1053/j.gastro.2009.08.042
13. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., et al. (2014). Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514. doi: 10.1038/nrgastro.2014.66
14. Jiang, Y., Yang, G., Meng, F., Yang, W., Hu, J., Ye, L., et al. (2016). Immunological mechanisms involved in probiotic-mediated protection against Citrobacter rodentium-induced colitis. Benef. Microbes 7, 397-407. doi: 10.3920/BM2015.0119
15. Kaser, A., Zeissig, S., and Blumberg, R. S. (2010). Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621. doi: 10.1146/annurev-immunol-030409-101225
16. Kashyap, P. C., Chia, N., Nelson, H., Segal, E., and Elinav, E. (2017). Microbiome at the frontier of personalized medicine. Mayo Clin. Proc. 92, 1855-1864. doi: 10.1016/j.mayocp.2017.10.004
17. Kim, M. S., Byun, J. S., Yoon, Y. S., Yum, D. Y., Chung, M. J., and Lee, J. C. (2017). A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production. Benef. Microbes 8, 231-241. doi: 10.3920/BM2016.0031
18. Lee, S. M., Donaldson, G. P., Mikulski, Z., Boyajian, S., Ley, K., and Mazmanian, S. K. (2013). Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426-429. doi: 10.1038/nature12447
19. Leone, V. A., Cham, C. M., and Chang, E. B. (2014). Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases? Curr. Opin. Immunol. 31, 16-23. doi: 10.1016/j.coi.2014.08.004
20. Litvak, Y., Byndloss, M. X., Tsolis, R. M., and Baumler, A. J. (2017). Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr. Opin. Microbiol. 39, 1-6. doi: 10.1016/j.mib.2017.07.003
21. Macpherson, A. J., De Aguero, M. G., and Ganal-Vonarburg, S. C. (2017). How nutrition and the maternal microbiota shape the neonatal immune system. Nat. Rev. Immunol. 17, 508-517. doi: 10.1038/nri.2017.58
22. Maldonado-Gomez, M. X., Martinez, I., Bottacini, F., O'callaghan, A., Ventura, M., Van Sinderen, D., et al. (2016). Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20, 515-526. doi: 10.1016/j.chom.2016.09.001
23. Martin, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., et al. (2015). Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 15:67. doi: 10.1186/s12866-015-0400-1
24. Park, S. Y., Kim, J. S., Seo, Y. R., and Sung, M. K. (2012). Effects of diet-induced obesity on colitis-associated colon tumor formation in A/J mice. Int. J. Obes. 36, 273-280. doi: 10.1038/ijo.2011.83
25. Rath, H. C., Herfarth, H. H., Ikeda, J. S., Grenther, W. B., Hamm, TE Jr, Balish, E., et al. (1996). Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest. 98, 945-953.
26. Round, J. L., and Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323. doi: 10.1038/nri2515
27. Ruemmele, F. M. (2016). Role of diet in inflammatory bowel disease. Ann. Nutr. Metab. 68(Suppl. 1), 33-41.
28. Saulnier, D. M., Ringel, Y., Heyman, M. B., Foster, J. A., Bercik, P., Shulman, R. J., et al. (2013). The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 4, 17-27. doi: 10.4161/gmic.22973
29. Schieber, A. M., Lee, Y. M., Chang, M. W., Leblanc, M., Collins, B., Downes, M., et al. (2015). Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling. Science 350, 558-563. doi: 10.1126/science.aac6468
30. Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., et al. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231.
31. Statovci, D., Aguilera, M., Macsharry, J., and Melgar, S. (2017). The impact of western diet and nutrients on the microbiota and immune response at mucosal interfaces. Front. Immunol. 8:838. doi: 10.3389/fimmu.2017.00838
32. Stecher, B., Chaffron, S., Kappeli, R., Hapfelmeier, S., Freedrich, S., Weber, T. C., et al. (2010). Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6:e1000711. doi: 10.1371/journal.ppat.1000711
33. Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernandez-Sueiro, J. L., et al. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364.
34. Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., et al. (2018). Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 359, 1376-1383. doi: 10.1126/science.aar3318
35. van der Beek, C. M., Dejong, C. H. C., Troost, F. J., Masclee, A. A. M., and Lenaerts, K. (2017). Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr. Rev. 75, 286-305. doi: 10.1093/nutrit/nuw067
36. Wei, Y., Yang, F., Wu, Q., Gao, J., Liu, W., Liu, C., et al. (2018). Protective effects of bifidobacterial strains against toxigenic Clostridium difficile. Front. Microbiol. 9:888. doi: 10.3389/fmicb.2018.00888
37. Wei, Y. X., Zhang, Z. Y., Liu, C., Zhu, Y. Z., Zhu, Y. Q., Zheng, H., et al. (2010). Complete genome sequence of Bifidobacterium longum JDM301. J. Bacteriol. 192, 4076-4077. doi: 10.1128/JB.00538-10
38. Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Jarnerot, G., Engstrand, L., et al. (2009). Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15, 653-660. doi: 10.1002/ibd.20783
39. Yamamoto, T., Shimoyama, T., and Kuriyama, M. (2017). Dietary and enteral interventions for Crohn's disease. Curr. Opin. Biotechnol. 44, 69-73. doi: 10.1016/j.copbio.2016.11.011
40. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094. doi: 10.1016/j.cell.2015.11.001